Pharmaceutical Manufacturing News - Latest Updates & Headlines
FDI in India's pharma sector crosses Rs 19,134 crore during 2024-25
New Delhi, April 13: India's pharmaceuticals and medical devices sector has seen a FDI inflow to the tune of Rs 11,888 crore from April to December in the financial year ended on March 31, 2025, apart from which 13 FDI proposals worth Rs 7,246.40 crore for brownfield projects during 2024-25 have been approved, taking the total FDI to Rs 19,134.4 crore, according to figures compiled by the Department of Pharmaceuticals.
Who's going to pay price to bring back manufacturing in US, asks Biocon MD amid possibility of tariffs on pharma
New Delhi, April 11: Siddharth Mittal, CEO and Managing Director of Biocon Limited, on Friday questioned who would pay the price to shift their establishments to the US where pharma manufacturing costs are higher than in India and China.
Johnson & Johnson increases US investment to more than USD 55 billion over next 4 yrs
Washington, DC, March 22: Johnson and Johnson, US healthcare's leading, most comprehensive innovation powerhouse, announced on Friday that it will invest more than USD 55 billion in manufacturing, research and development, and technology in the United States over the next four years.
Indian API market to expand to $22 bn by 2030, at a CAGR of 8.3 pc: Report
New Delhi, March 3: India's Active Pharmaceutical Ingredients (APIs) market is expected to expand to $22 billion by 2030, according to a report on Monday.
Timeline for Small Pharma Manufacturers' compliance with revised schedule 'M' extended
New Delhi, February 13: The Ministry of Health & Family Welfare has conditionally extended the due date for implementation of revised Schedule M (Good Manufacturing Practices provision) in respect of small and medium manufacturers having turnover of Rs. 250 crores or less, up to December 31, as stated in press release.
India's CDMO market set to double by 2028 amid Asia's healthcare boom
New Delhi, February 9: India's Contract Development and Manufacturing Organization (CDMO) market is poised for exponential growth, expected to expand from USD 7 billion to USD 14 billion by 2028, capturing 4-5 per cent of the global market, according to BCG report.
China+1 opens larger share for India in global pharma manufacturing beyond generics: BCG report
New Delhi, January 27: India is poised to capture a bigger share of the global pharmaceutical manufacturing market beyond generics, according to a report by Boston Consulting Group (BCG).